Morgan Stanley’s Vincerx Pharma, Inc. Warrant VINCW Stock Holding History

Morgan Stanley’s Portfolio VINCW Stock Details VINCW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3,500	Closed	-$14K	–	7967
2021 Q1	$14K	Hold	3,500	–	–	﹤0.01%	6858
2020 Q4	$12K	Buy	+3,500	New	+$11.6K	﹤0.01%	6597

Morgan Stanley's VINCW Position: Q2 2021 in Review

Morgan Stanley sold out of Vincerx Pharma, Inc. Warrant (VINCW) in Q2 2021, closing a stake of 3,500 shares — an estimated $14K sold.

Morgan Stanley first reported a position in VINCW in Q4 2020 and held it in 2 quarters. The position peaked at $14K in Q1 2021. 0 funds tracked by Wall St. Rank hold VINCW as of Q2 2021.

Morgan Stanley reported no remaining Vincerx Pharma, Inc. Warrant position as of Q2 2021 after selling out during the quarter.
Morgan Stanley sold 3,500 Vincerx Pharma, Inc. Warrant shares in Q2 2021, an estimated $14K.
Morgan Stanley first reported a position in Vincerx Pharma, Inc. Warrant in Q4 2020 and held it in 2 quarters.
Morgan Stanley's Vincerx Pharma, Inc. Warrant position peaked at $14K in Q1 2021.
0 funds tracked by Wall St. Rank held Vincerx Pharma, Inc. Warrant as of Q2 2021.

Based on Morgan Stanley's 13F filing for Q2 2021, filed 16 Aug 2021.